AARP Hearing Center
Key takeaways
- Early sign-ups urged for Medicare drug payment plan.
- AARP fought for law to create program, simplify billing.
- Current drug payment plan participation is low.
- Few Part D enrollees know about payment program.
- Some unclear on benefits, worry about missing payments.
Medicare enrollees with high prescription bills should sign up soon for an underused federal program that lets you spread your Part D out-of-pocket drug costs throughout 2026 rather than paying all at once.
Launched in 2025, the Medicare Prescription Payment Plan (MPPP) allows beneficiaries in stand-alone Medicare prescription drug plans and Medicare Advantage plans with drug coverage to pay their high Part D costs in monthly installments to their plans, not all at once to the pharmacy. This means a January bill for $2,100, the Part D out-of-pocket limit for 2026, could be paid off by year’s end for an average of $175 a month through the program.
Even if you start in April, you would be able to pay a little more than $233 a month until the end of the year. And you won’t be charged interest like with a credit card or an installment loan.
Earlier means more months to space out payments
While you can enroll at any time during the year, if you sign up early, you’ll have more time to spread out the payments. People who could benefit most from early enrollment include those who don’t qualify for low-income subsidies such as Medicare’s Extra Help Program and those who have high Part D costs at the start of the year, such as cancer patients and those taking expensive Part D specialty drugs.
“That’s why we’re so intent about spreading the word about MPPP,” says John Lin, an oncologist and assistant professor in the department of health services research at the University of Texas MD Anderson Cancer Center in Houston.
Lin and Jalpa Doshi, a health economist and professor at the University of Pennsylvania’s Perelman School of Medicine in Philadelphia, are among a handful of experts pushing for increased program enrollment. They published research last year that showed the Part D out-of-pocket cap alone wasn’t fixing the affordability problem since many cancer patients can’t afford to pay the full out-of-pocket limit all at once early in a year, as some drugs require.
Join our fight to protect Medicare
AARP is working to keep Medicare strong. Here’s how you can help.
- Sign up to become an AARP activist for the latest news and alerts on issues you care about.
- Find out more about how we’re fighting for you in Congress and across the country.
- See the latest AARP research on Medicare and more.
- AARP is your fierce defender on the issues that matter to people 50-plus. Become a member or renew your membership today.
“We had way too many patients who were abandoning their cancer prescriptions at the counter” due to cost, says Doshi, whose research team highlighted the need for a program like the Medicare Prescription Payment Plan back in 2016.
With the program’s lower installment payments — and the $2,100 out-of-pocket cap in 2026 — George Valentine, 74, of Irving, Texas, says he can finally afford all of his out-of-pocket costs for expensive medications to treat chronic lymphocytic leukemia.
“Between me, my savings, my family and this, that and the other, I can handle $2,100 a year,” Valentine says of the 2026 annual Part D payment limit. “And, certainly, at a monthly rate? I can handle that.”
The payment plan’s 2025 launch provided even more financial relief for Valentine, who had received a grant from the Patient Access Network (PAN) Foundation in Washington, D.C., to help pay for the medications that keep him alive. Valentine didn’t request another grant from PAN for 2025 or 2026.
“When I don’t reapply, those funds get freed up to help other people,” he says.
AARP fought for law that created drug program
The payment option is part of a sweeping 2022 prescription drug law, which AARP supported, that also capped Part D out-of-pocket costs at $2,000 in 2025 — now $2,100 in 2026 and $2,400 in 2027. The legislation also allowed Medicare to negotiate lower drug prices directly with pharmaceutical companies.
The Medicare Prescription Payment Program doesn’t lower prescription costs. It’s designed to improve affordability by helping people budget for their Part D expenses. That could help avoid cost-related interruptions in their therapy.
Drug plans must notify a pharmacy when a Part D beneficiary’s out-of-pocket costs for Part D–covered drugs hit $600, and the pharmacy must then inform the patient they are “likely to benefit” from the payment plan option.
Next in series
12 Things Caregivers Need to Know About Medicare — and 1 They Wish Would Change
Learn how to navigate the system to get the best coverage for your loved one